alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<MULTIPLIER>                                           1,000
<CURRENCY>                                      U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                                DEC-31-2000
<PERIOD-START>                                   JUL-01-2000
<PERIOD-END>                                     SEP-30-2000
<EXCHANGE-RATE>                                            1
<CASH>                                               482,369
<SECURITIES>                                               0
<RECEIVABLES>                                        853,543
<ALLOWANCES>                                               0
<INVENTORY>                                        2,586,049
<CURRENT-ASSETS>                                   4,054,538
<PP&E>                                             4,025,452
<DEPRECIATION>                                    (3,286,255)
<TOTAL-ASSETS>                                     4,871,325
<CURRENT-LIABILITIES>                              5,718,039
<BONDS>                                                6,635
<PREFERRED-MANDATORY>                              2,599,171
<PREFERRED>                                                0
<COMMON>                                          51,144,655
<OTHER-SE>                                       (54,741,609)
<TOTAL-LIABILITY-AND-EQUITY>                       4,871,325
<SALES>                                            4,377,615
<TOTAL-REVENUES>                                   4,147,372
<CGS>                                              2,790,118
<TOTAL-COSTS>                                      2,790,118
<OTHER-EXPENSES>                                     566,242
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                    98,070
<INCOME-PRETAX>                                      138,958
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                                  138,958
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                         138,958
<EPS-BASIC>                                             0.01
<EPS-DILUTED>                                           0.00


</TABLE>
#### STATE OF NEW JERSEY, DEFENDANT IN ERROR, v. CHARLES HARRIS, PLAINTIFF IN ERROR.

Argued October 17, 1944

Decided January 4, 1945.

For the plaintiff in error, *Edward A. Reid.*

For the defendant in error, *Gene R. Mariano.*

Per Curiam.

The judgment herein is affirmed by an equally divided court.

*For affirmance*— The Chancellor, Case, Bobine, Dongbs, Porter, Wells, Thompson, JJ. 7.

*For reversal*— The Chief Justice, Parker, Perskie, Colie, Raeeerty, Hague, Dtll, JJ. 7.
#### STATE OF NEW JERSEY v. ROBERT RAINE.

October 20, 1987.

Petition for certification denied.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

IN RE: M.B. AND M.M.

PETITION OF: A.B.

:

:

:

:

No. 90 MM 2017

ORDER

PER CURIAM

AND NOW, this 6th day of July, 2017, the Petition for Leave to File a Petition for 

Allowance of Appeal Nunc Pro Tunc is GRANTED. Counsel is DIRECTED to submit 

the already-prepared Petition for Allowance of Appeal within five days.
#### CAROLYN COLEMAN v. FIORE BROTHERS, INC. AGNES HOLMES v. FIORE BROTHERS, INC. FRANK ROBINSON v. FIORE BROTHERS, INC. LILLIAN SHEFFIELD v. FIORE BROTHERS, INC.

November 17, 1987.

Petition for certification granted.
#### RICHARDO ALVAREZ, ET AL. v. QUADRELLE TEXTILE CORPORATION, ETC., ET AL.

January 21, 1987.

Petition for certification denied.
##### 



Hudson City Bancorp, Inc.
Form 10-Q EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Denis J. Salamone, certify that:  1.
    
    I have reviewed this Quarterly Report on Form 10-Q of Hudson City Bancorp,
Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;3.
    
    Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the registrant as of and for, the periods presented in this
report;4.
    
    The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
and have:  a.
    
    Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this report is being prepared;b.
    
    (paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986);c.
    
    Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such
evaluation; andd.
    
    Disclosed in this quarterly report any change in the
registrants internal control over financial reporting that occurred
during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect,
the registrants internal control over financial reporting; and  5.
    
    The registrants other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,
to the registrants auditors and the audit committee of the registrants
board of directors (or persons performing the equivalent functions):  a)
    
    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; andb)
    
    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants
internal control over financial reporting. Date: November 5, 2004
    
    By:
    
    /s/ Denis J. SalamoneDenis J. SalamoneSenior Executive Vice President
and Chief Operating Officer
 Page 39
#### STATE OF NEW JERSEY v. DERRICK LAWRENCE.

October 20, 1987.

Petition for certification denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE JUNE 30,
2000 BALANCE SHEET AND THE STATEMENT OF INCOME AND RETAINED EARNINGS FOR THE SIX
MONTHS ENDED JUNE 30, 2000 INCLUDED IN THE COMPANY'S JUNE 30, 2000 10-Q AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 10-Q.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          36,064
<SECURITIES>                                         0
<RECEIVABLES>                                5,951,273<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,987,337
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              84,487,337<F2>
<CURRENT-LIABILITIES>                               24
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  2,726,700
<COMMON>                                         2,000
<OTHER-SE>                                  81,758,613<F3>
<TOTAL-LIABILITY-AND-EQUITY>                84,487,337
<SALES>                                              0
<TOTAL-REVENUES>                             3,007,254<F4>
<CGS>                                                0
<TOTAL-COSTS>                                   41,276
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              2,965,978
<INCOME-TAX>                                    43,000
<INCOME-CONTINUING>                          2,922,978
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,922,978
<EPS-BASIC>                                     2.26
<EPS-DILUTED>                                     2.26
<FN>
<F1>Receivables are due from affiliated companies.
<F2>An investment in preferred shares of Chieftain International (U.S.) Inc., at
cost of $78,500,000 has been included in total assets.
<F3>Additional paid-in capital of $14,998,000 (attributable to common stock) and
$60,676,203 (attributable to preferred stock) has been added to retained
earnings of $6,084,410 in calculating other stockholders' equity.
<F4>Revenues are earned exclusively from transactions with parent company.
</FN>


</TABLE>
584 A.2d 202

#### STATE OF NEW JERSEY v. PHILLIP PARSONS.

May 1, 1990.

Petition for certification denied.
I 

115TH CONGRESS 

1ST SESSION H. R. 841 

To prohibit the appropriation of funds to the Executive Office of the President 

until the restoration of the White House phone-in comment line. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2017 

Ms. SPEIER (for herself, Mr. COHEN, Mrs. WATSON COLEMAN, Ms. PINGREE, 

Ms. DELAURO, Ms. SHEA-PORTER, Ms. CLARKE of New York, Mr. 

MEEKS, Mr. SOTO, Ms. SLAUGHTER, Mr. TAKANO, Mr. MCGOVERN, Mr. 

GARAMENDI, Mr. BLUMENAUER, Ms. ESHOO, and Mr. ELLISON) introduced the following bill; which was referred to the Committee on Oversight and Government Reform 

A BILL 

To prohibit the appropriation of funds to the Executive Office of the President until the restoration of the White 

House phone-in comment line. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Phone The White 

5 House Act’’. 

6 SEC. 2. PROHIBITION ON FUNDS. 

7 No funds are authorized to be appropriated to the 

8 Executive Office of the President for any period during 


smartinez on DSK3GLQ082PROD with BILLS
2 

•HR 841 IH

1 which a system is not in effect in which members of the 

2 public may submit comments to the Office by telephone. 

Æ 


smartinez on DSK3GLQ082PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of General Medical Sciences Special Emphasis Panel; Review of Minority Biomedical Research Neuro Grant Applications.                    

*Date:*                         November 12, 2010.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency-Bethesda, 7400 Wisconsin Avenue, One Bethesda Metro Center, Bethesda, MD 20814.                    

*Contact Person:*                         John J. Laffan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18J, Bethesda, MD 20892, 301-594-2773,                         *laffanjo@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS)

Dated: October 12, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-26185 Filed 10-15-10; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 4.382

 

/Emblem of the Russian Federation/

 

FEDERAL SERVICE FOR SUPERVISION IN THE SPHERE OF COMMUNICATIONS, INFORMATION TECHNOLOGY AND MASS MEDIA

 

LICENSE

 

No. 173073 dated July 02, 2019

 

For Rendering

 

telecommunication services for provision of communication channels

 

This License is granted to

 

Public Joint Stock Company

 

Mobile TeleSystems

 

Primary State Registration Number of a Legal Entity 

(Individual Entrepreneur) (OGRN, OGRNIP)

 

1027700149124

 

Tax Identification Number (TIN)

 

7740000076

 











 

Location address (place of residence):

 

4, Marksistskaya str., Moscow, 109147

 

The territory covered by telecommunications services is specified in the Appendix.

 

This License is granted for a term:

 

until July 02, 2024.

 

This License is granted by decision of the licensing body - Order dated March 28, 2019 No. 189-рчс

 

Appendix being an integral part of this license is executed on 2 sheets.

 

	
Deputy Head
    	
 
    	
/signature/   A.А. Pankov
    
	
 
    	
 
    	
 
    
	
Stamp here
    	
 
    	
 
    
	
Official seal:

MINISTRY OF TELECOM AND MASS COMMUNICATIONS 
   OF THE RUSSIAN FEDERATION 
   FEDERAL SERVICE FOR SUPERVISION IN THE SPHERE 
   OF COMMUNICATIONS, INFORMATION TECHNOLOGY 
   AND MASS MEDIA 
   PSRN 1087746736296
----

----

Exhibit 32.1 

SECTION 1350 CERTIFICATION 

| 1)     |   | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and                            |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                 |
| 2)     |   | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

|                                                                                                                                                                                                                   |   |   |   |   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|--------|
| /s/ Jay Gottlieb                                  |   |   |
| Jay Gottlieb                                                                                                                                                                                                      |   |   |
| Chairman of the Board, President, Secretary, Treasurer and Principal Executive Officer                                                                                                                                 |   |   |
|                                                                                                                                                                                                                   |

----

----
#### PHILIP CAPODILUPO v. BOARD OF EDUCATION OF THE TOWNSHIP OF WEST ORANGE.

December 8, 1987.

Petition for certification denied.
#### STATE OF NEW JERSEY v. THOMAS MISERENDINO.

May 28, 1987.

Petition for certification denied.
584 A.2d 249

#### STATE OF NEW JERSEY v. ROBERT J. BROWN.

June 11, 1990.

Petition for certification denied.
United States Court of Appeals for the Federal Circuit 

02-1052, -1065 

INTEGRA LIFESCIENCES I, LTD. and THE BURNHAM INSTITUTE, 

Plaintiffs-Cross Appellants, 

and 

TELIOS PHARMACEUTICALS, INC., 

Plaintiff-Appellee, 

v. 

MERCK KGaA, 

Defendant-Appellant, 

and 

THE SCRIPPS RESEARCH INSTITUTE and DR. DAVID A. CHERESH, 

Defendants. 

Donald R. Dunner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of 

Washington, DC, argued for defendant-appellant Merck KGaA. With him on the brief were 

Thomas H. Jenkins, David A. Manspeizer, and Rachel H. Townsend. Of counsel on the brief 

were M. Patricia Thayer, Heller Ehrman White & McAuliffe, LLP, of San Francisco, California; 

and William C. Rooklidge, Howrey Simon Arnold & White, LLP, of Irvine, California. Of 

counsel was Esther H. Lim, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of 

Washington, DC. 

 

Mauricio A. Flores, Campbell & Flores LLP, of San Diego, California, argued for 

plaintiffs-cross appellants Integra LifeSciences I, Ltd. and The Burnham Institute. With him 

on the brief was David M. Beckwith. Of counsel on the brief were Raphael V. Lupo, Mark G. 

Davis, and Natalia V. Blinkova, McDermott, Will & Emery, of Washington, DC. Of counsel 

was Donna M. Tanguay. 

Appealed from: United States District Court for the Southern District of California 

Senior Judge James M. Fitzgerald, District of Alaska 
United States Court of Appeals for the Federal Circuit

 02-1052, -1065 

 INTEGRA LIFESCIENCES I, LTD. and THE BURNHAM INSTITUTE, 

Plaintiffs-Cross Appellants, 

 and 

TELIOS PHARMACEUTICALS, INC., 

Plaintiff-Appellee, 

 v. 

 MERCK KGaA, 

Defendant-Appellant, 

 and 

 THE SCRIPPS RESEARCH INSTITUTE and DR. DAVID A. CHERESH, 

Defendants. 

Before NEWMAN, RADER, and PROST, Circuit Judges. 

O R D E R

The court has received a certified copy of the judgment from the Clerk of the 

Supreme Court of the United States in Merck KGaA v. Integra Lifesciences I, Ltd., No. 03-

1237. The Supreme Court vacated this court's judgment, which was reported at 331 F.3d 

860 (Fed. Cir. 2003), and remanded for proceedings consistent with the Court's opinion. 
02-1052, -1065 2 

Upon consideration thereof, 

IT IS ORDERED THAT: 

(1) The mandate is hereby recalled and the appeal is reinstated. 

(2) The case is returned to the original merits panel. 

(3) New briefs shall be filed, with particular attention paid to the Supreme Court 

decision. 

(4) The appellants' principal brief shall be due within 60 days of the date of filing 

of this order. The dates for filing the remaining briefs shall be in accordance with Fed. Cir. 

R. 31(a). An original and 22 copies of all briefs shall be filed, and two copies shall be 

served on opposing counsel. The court sua sponte allows amicus briefs. 

FOR THE COURT 

_Aug 17 2005__ _s/Jan Horbaly_____ 

Date Jan Horbaly 

Clerk 

cc: Donald R. Dunner, Esq. 

Mauricio A. Flores, Esq.
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Park Hotels & Resorts Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas J. Baltimore, Jr., President and Chief Executive Officer of the Company, in my capacity as an officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

|   | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

 

| Date: March 2, 2017 |   | By:    | /s/ Thomas J. Baltimore, Jr.     |
|---------------------|--------|--------|---------------------------------------|
|                |   |   | Thomas J. Baltimore, Jr.              |
|                |   |   | President and Chief Executive Officer |

 

 

 

 

In accordance with SEC Release NO. 34-47986, this Exhibit is furnished to the SEC as an accompanying document and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended.
No. 87-1195.

#### Williams *v.*Lawyers Professional Responsibility Board of Minnesota.

Appeal from Sup. Ct. Minn, dismissed for want of substantial federal question.